View Item 

Show simple item record

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology
dc.contributor.authorVidal, Claudia I.
dc.contributor.authorArmbrect, Eric A.
dc.contributor.authorAndea, Aleodor A.
dc.contributor.authorBohlke, Angela K.
dc.contributor.authorComfere, Nneka I.
dc.contributor.authorHughes, Sarah R.
dc.contributor.authorKim, Jinah
dc.contributor.authorKozel, Jessica A.
dc.contributor.authorLee, Jason B.
dc.contributor.authorLinos, Konstantinos
dc.contributor.authorLitzner, Brandon R.
dc.contributor.authorMissall, Tricia A.
dc.contributor.authorNovoa, Roberto A.
dc.contributor.authorSundram, Uma
dc.contributor.authorSwick, Brian L.
dc.contributor.authorHurley, Maria Yadira
dc.contributor.authorAlam, Murad
dc.contributor.authorArgenyi, Zsolt
dc.contributor.authorDuncan, Lyn M.
dc.contributor.authorElston, Dirk M.
dc.contributor.authorEmanuel, Patrick O.
dc.contributor.authorFerringer, Tammie
dc.contributor.authorFung, Maxwell A.
dc.contributor.authorHosler, Gregory A.
dc.contributor.authorLazar, Alexander J.
dc.contributor.authorLowe, Lori
dc.contributor.authorPlaza, Jose A.
dc.contributor.authorPrieto, Victor G.
dc.contributor.authorRobinson, June K.
dc.contributor.authorSchaffer, Andras
dc.contributor.authorSubtil, Antonio
dc.contributor.authorWang, Wei‐lien
dc.date.accessioned2018-08-13T18:48:37Z
dc.date.available2019-10-01T16:02:10Zen
dc.date.issued2018-08
dc.identifier.citationVidal, Claudia I.; Armbrect, Eric A.; Andea, Aleodor A.; Bohlke, Angela K.; Comfere, Nneka I.; Hughes, Sarah R.; Kim, Jinah; Kozel, Jessica A.; Lee, Jason B.; Linos, Konstantinos; Litzner, Brandon R.; Missall, Tricia A.; Novoa, Roberto A.; Sundram, Uma; Swick, Brian L.; Hurley, Maria Yadira; Alam, Murad; Argenyi, Zsolt; Duncan, Lyn M.; Elston, Dirk M.; Emanuel, Patrick O.; Ferringer, Tammie; Fung, Maxwell A.; Hosler, Gregory A.; Lazar, Alexander J.; Lowe, Lori; Plaza, Jose A.; Prieto, Victor G.; Robinson, June K.; Schaffer, Andras; Subtil, Antonio; Wang, Wei‐lien (2018). "Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology." Journal of Cutaneous Pathology 45(8): 563-580.
dc.identifier.issn0303-6987
dc.identifier.issn1600-0560
dc.identifier.urihttps://hdl.handle.net/2027.42/145218
dc.publisherBlackwell Publishing Ltd
dc.publisherWiley Periodicals, Inc.
dc.subject.otherexpert rating
dc.subject.otherancillary studies
dc.subject.otherappropriate use criteria
dc.subject.otherdermatopathology
dc.subject.otherevidenceâ based medicine
dc.titleAppropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDermatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145218/1/cup13142.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145218/2/cup13142_am.pdf
dc.identifier.doi10.1111/cup.13142
dc.identifier.sourceJournal of Cutaneous Pathology
dc.identifier.citedreferenceGiardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of lynch syndrome: a consensus statement by the US multiâ society task force on colorectal cancer. Am J Gastroenterol. 2014; 109: 1159 â 1179.
dc.identifier.citedreferenceBrook RH, Vaiana ME. Using the knowledge base of health services research to redefine health care systems. J Gen Intern Med. 2015; 30 ( 10 ): 1547 â 1556.
dc.identifier.citedreferenceKuntz KM, Tsevat J, Weinstein MC, Goldman L. Expert panel vs decisionâ analysis recommendations for postdischarge coronary angiography after myocardial infarction. JAMA. 1999; 282 ( 23 ): 2246 â 2251.
dc.identifier.citedreferenceFitch K, Bernstein S, Aguilar MS, et al. The RAND/UCLA Appropriateness Method User’s Manual 2001. No. MRâ 1269â DGâ XII/RE:126. Santa Monica, CA: RAND Corp.; 2001.
dc.identifier.citedreferenceBerg G, Jaffe ES, Kempf W, et al. WHO/EORTC classification of cutaneous lymphomas. In: LeBoit PE, Burg G, Weedon D, Sarasin A, eds. WHO Classification of Skin Tumors. 4th ed. Lyon, France: IARC Press; 2006: 165 â 228.
dc.identifier.citedreferenceMartinez G, Copen CE, Abma JC. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006â 2010 National Survey of family growth. National Center for Health Statistics. Vital Health Stat. 2011; 23 ( 31 ):1â 35.
dc.identifier.citedreferenceCalonje E, Brenn T, Lazar A, McKee PH, eds. McKee’s Pathology of the Skin. 4th ed. China: Elsevier/Sanders; 2012.
dc.identifier.citedreferenceGill D, Dorevitch A, Marks R. The prevalence of seborrheic keratoses in people age 15 to 30 years: is the term senile keratosis redundant? Arch Dermatol. 2000; 136 ( 6 ): 759 â 762.
dc.identifier.citedreferenceJohn AM, Schwartz RA. Muirâ Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol. 2016; 74 ( 3 ): 558 â 566.
dc.identifier.citedreferenceBhaijee F, Brown AS. Muirâ Torre syndrome. Arch Pathol Lab Med. 2014; 138 ( 12 ): 1685 â 1689.
dc.identifier.citedreferenceComfere NI, Sundram U, Hurley MY, Swick BL. Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T cell and B cell lymphoproliferative disorders. J Cutan Pathol. 2018; 45 ( 1 ): 39 â 47.
dc.identifier.citedreferenceEmanuel PO, Andea AA, Vidal CI, et al. Review of the medical literature and assessment of current utilization patterns regarding molecular testing for the diagnosis of cutaneous melanoma. J Cutan Pathol. [Submitted].
dc.identifier.citedreferenceLitzner BR, Lee JB, Vidal CI. Review of the current medical literature and assessment of current utilization patterns regarding human papillomavirus in situ hybridization and immunohistochemistry in dermatopathology. J Cutan Pathol. 2017; 44 ( 11 ): 938 â 943.
dc.identifier.citedreferenceLee JB, Litzner BR, Vidal CI. Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muirâ Torre syndromeâ associated neoplasms. J Cutan Pathol. 2017; 44 ( 11 ): 931 â 937.
dc.identifier.citedreferenceKonstantinos L, Kozel JA, Hurley MY, Andea AA. Review of the medical literature and assessment of current utilization patterns regarding the use of two common fluorescence in situ hybridization assays for the diagnosis of dermatofibrosarcoma protuberans and clear cell sarcoma. J Cutan Pathol. [Submitted].
dc.identifier.citedreferencePouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P. Distinguishing epithelioid blue nevus from blue nevusâ like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am J Surg Pathol. 2009; 33 ( 9 ): 1396 â 1400.
dc.identifier.citedreferenceGammon B, Beilfuss B, Guitart J, Busam KJ, Gerami P. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevusâ like melanoma. J Cutan Pathol. 2011; 38 ( 4 ): 335 â 341.
dc.identifier.citedreferenceGerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J Cutan Pathol. 2011; 38 ( 4 ): 329 â 334.
dc.identifier.citedreferenceClarke LE, Warf MB. Flake DD 2nd, et al.. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol. 2015; 42 ( 4 ): 244 â 252.
dc.identifier.citedreferenceClarke LE, Flake DD 2nd, Busam K, et al. An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi. Cancer 2017; 123 ( 4 ): 617 â 628.
dc.identifier.citedreferenceMinca EC, Alâ Rohil RN, Wang M, et al. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions. Mod Pathol. 2016; 29 ( 8 ): 832 â 843.
dc.identifier.citedreferenceCockerell C, Tschen J, Billings SD, et al. The influence of a geneâ expression signature on the treatment of diagnostically challenging melanocytic lesions. Per Med. 2017; 14 ( 2 ): 123 â 130.
dc.identifier.citedreferenceKo JS, Matharooâ Ball B, Billings SD, et al. Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes. Cancer Epidemiol Biomarkers Prev. 2017; 26 ( 7 ): 1107 â 1113.
dc.identifier.citedreferenceAguileraâ Barrantes I, Magro C, Nuovo GJ. Verruca vulgaris of the vulva in children and adults: a nonvenereal type of vulvar wart. Am J Surg Pathol. 2007; 31: 529 â 535.
dc.identifier.citedreferenceNuovo GJ, Lastarria DA, Smith S, Lerner J, Comité SL, Eliezri YD. Human papillomavirus segregation patterns in genital and nongenital warts in prepubertal children and adults. Am J Clin Pathol. 1991; 95: 467 â 474.
dc.identifier.citedreferenceYun K, Joblin L. Presence of human papillomavirus DNA in condylomata acuminata in children and adolescents. Pathology. 1993; 25: 1 â 3.
dc.identifier.citedreferencePadel AF, Venning VA, Evans MF, Quantrill AM, Fleming KA. Human papillomaviruses in anogenital warts in children: typing by in situ hybridisation. BMJ. 1990; 300: 1491 â 1494.
dc.identifier.citedreferenceHandley J, Hanks E, Armstrong K, et al. Common association of HPV 2 with anogenital warts in prepubertal children. Pediatr Dermatol. 1997; 14: 339 â 343.
dc.identifier.citedreferenceSchwartz RA, Torre DP. The Muirâ Torre syndrome: a 25â year retrospect. J Am Acad Dermatol. 1995; 33: 90 â 104.
dc.identifier.citedreferenceEverett JN, Raymond VM, Dandapani M, et al. Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol. 2014; 150: 1315 â 1321.
dc.identifier.citedreferenceRoberts ME, Riegertâ Johnson DL, Thomas BC, et al. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muirâ Torre variant of Lynch syndrome. Genet Med. 2014; 16: 711 â 716.
dc.identifier.citedreferencePlocharczyk EF, Frankel WL, Hampel H, Peters SB. Mismatch repair protein deficiency is common in sebaceous neoplasms and suggests the importance of screening for lynch syndrome. Am J Dermatopathol. 2013; 35: 191 â 195.
dc.identifier.citedreferenceDores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF Jr. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muirâ Torre syndrome. Cancer 2008. 113 ( 12 ): 3372 â 81.
dc.identifier.citedreferenceMojtahed A, Schrijver I, Ford JM, Longacre TA, Pai RK. A twoâ antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol. 2011; 24 ( 7 ): 1004 â 1014.
dc.identifier.citedreferenceNaeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol. 1995; 147 ( 6 ): 1553 â 1558.
dc.identifier.citedreferencePoland KS, Shardy DL, Azim M, et al. Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia. Genes Chromosomes Cancer. 2009; 48 ( 6 ): 480 â 489.
dc.identifier.citedreferenceSimon MP, Pedeutour F, Sirvent N, et al. Deregulation of the plateletâ derived growth factor Bâ chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giantâ cell fibroblastoma. Nat Genet. 1997; 15 ( 1 ): 95 â 98.
dc.identifier.citedreferenceSirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer. 2003; 37 ( 1 ): 1 â 19.
dc.identifier.citedreferenceRutkowski P, Wozniak A, Switaj T. Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans. Sarcoma. 2011; 2011: 959132.
dc.identifier.citedreferenceRutkowski P, Van Glabbeke M, Rankin CJ, et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol. 2010; 28 ( 10 ): 1772 â 1779.
dc.identifier.citedreferenceSalgado R, Llombart B, M Pujol R, et al. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptaseâ polymerase chain reaction and fluorescence in situ hybridization methodologies. Genes Chromosomes Cancer. 2011; 50 ( 7 ): 510 â 517.
dc.identifier.citedreferencePapp G, Mihály D, Sápi Z. Unusual signal patterns of breakâ apart FISH probes used in the diagnosis of soft tissue sarcomas. Pathol Oncol Res. 2017; 23 ( 4 ): 863 â 871.
dc.identifier.citedreferenceHa SY, Lee SE, Kwon MJ, et al. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications. Hum Pathol. 2013; 44 ( 7 ): 1300 â 1309.
dc.identifier.citedreferenceKaranian M, Perot G, Coindre JM, Chibon F, Pedeutour F, Neuville A. Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans. Mod Pathol. 2015; 28 ( 2 ): 230 â 237.
dc.identifier.citedreferenceEnzinger FM. Clearâ cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer. 1965; 18: 1163 â 1174.
dc.identifier.citedreferenceChung EB, Enzinger FM. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol. 1983; 7 ( 5 ): 405 â 413.
dc.identifier.citedreferenceGraadt van Roggen JF, Mooi WJ, Hogendoorn PC. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol. 1998; 186 ( 1 ): 3 â 7.
dc.identifier.citedreferenceTakahira T, Oda Y, Tamiya S, et al. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma. Cancer Sci. 2004; 95 ( 8 ): 651 â 655.
dc.identifier.citedreferenceSegal NH, Pavlidis P, Noble WS, et al. Classification of clearâ cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol. 2003; 21 ( 9 ): 1775 â 1781.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cup13142.pdf
Size:
2.440MB
Format:
PDF
View/Open
Name:
cup13142_am.pdf
Size:
543.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.